市場調查報告書
商品編碼
1439937
填充飾面製造 - 全球市場考量、競爭狀況、市場預測 (2030)Fill Finish Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球填充塗料製造市場規模預計到2023年將達到95.9289億美元,到2030年將達到169.4787億美元,2024-2030年預測期間複合年增長率為9.99%。由於各種疾病導致對填充加工製造流程的需求增加、人為幹預較少以及污染可能性極小等因素,預計該市場將蓬勃發展。市場技術的進步以及該領域的併購預計將在預測期內(2024-2030 年)導致市場收入大幅成長。
填充飾面製造的市場動態
填充飾面製造市場的顯著驅動因素包括近年來由於腫瘤、神經系統疾病和 COVID-19 等多種疾病的爆發,對填充飾面製造的需求不斷增長。根據世界衛生組織 (WHO) (2023) 的數據,平均每年有 40 萬名兒童罹患癌症。文件進一步指出,2020年全球有1,000萬人死於癌症,包括肺癌、乳癌、結腸癌和攝護腺癌。此外,根據世界衛生組織(2023)的數據,目前約有 5,500 萬人患有癡呆症,預計到 2030 年這一數字將增至 7,800 萬,到 2050 年將增至 1.39 億。所有這些疾病都需要治療藥物、生物製劑和其他有利於患者生存的藥物形式的醫療援助,這將增加未來幾年對填充劑製造市場的需求。
此外,在預測期內,灌裝製造市場不斷增加的併購預計將刺激市場對高品質藥品和設備的需求。例如,2020 年 1 月,為製藥和生物製品行業提供完全整合、客製化、端到端客製化解決方案的供應商 Alcami Corporation 宣佈推出 TriPharm Services,這是一個最先進的無菌灌裝製造中心位於北卡羅來納州的解決方案。被收購。最近的這些發展將有助於擴大向更廣泛的人群提供填充精加工服務,從而推動整個填充精加工製造市場在給定的預測期內向前發展。
然而,填充成品產品的高成本以及由於缺乏訓練有素的專業人員而增加的污染可能性導致欠發達國家和發展中國家採用和獲得填充成品製造的機會較少,這可能會限制市場成長。
在 COVID-19 大流行期間,填充飾面製造市場顯示出顯著增長。隨著 COVID-19 病例的增加,對藥物和生物製劑的需求急劇增加,導致產量激增。此外,全球疫苗研發活動和大規模生產需求進一步推動了市場成長。此外,大量生產設施和行業的開放、對用於大規模免疫的藥品和潛在生物製劑生產的需求不斷增加,以防止未來進一步的流行病,將在2024 年至2030 年的預測期內推動灌裝生產。整體市場。
填充飾面製造市場細分分析
在灌裝製造市場的產品領域,消耗品類別預計在預測期內(2024-2030年)整個市場的收入將顯著成長。
這可以歸因於消耗品的使用不斷增加、未來需要新的消耗品來維持無菌,以及以產品發佈的形式不斷發展的技術發展,這些都推動了灌裝製造市場的發展。預計將推動對消耗品的需求在產品領域。
消耗品包括注射器、小瓶和其他類型的設備,這些設備只能使用一次,並且必須丟棄以保持無菌。冷凍乾燥中小瓶等消耗品的使用不斷增加,以及生物製品中一次性包裝的使用不斷增加,是推動該產品領域對灌裝製造市場需求的多種因素。
該報告提供了全球填充飾面製造市場的研究和分析,包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。
Fill Finish Manufacturing Market By Product (Consumables [Prefilled Syringes, Vials, Cartridges, And Others], Instruments [By System Type {Integrated And Standalone}, By Machine Type {Automated, Semi-Automated And Manual}], By End-User (Contract Manufacturing Organizations, Pharmaceutical & Biopharmaceutical Companies, And Others), and by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to the growing demand for fill finish manufacturing, along with the rising technological advancement and merger acquisitions during the given forecast period.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030. The Fill Finish Manufacturing Market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes owing to a variety of diseases, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Fill Finish Manufacturing Market Dynamics:
Among the noteworthy drivers of the fill-finish manufacturing market, is the rising demand for fill-finish manufacturing in recent times owing to the prevalence of a variety of diseases such as oncological and neurological, and the onset of COVID-19, among others. According to the World Health Organization (2023), 400,000 children develop cancer every year on average. The source further stated that cancer caused 10 million deaths worldwide in 2020, such as lung, breast, colon & rectum, and prostate cancer. Moreover, as per WHO (2023), around 55 million people are currently living with dementia, and this number is expected to rise to 78 million in 2030 and 139 million in 2050. All the given conditions would require medical assistance in the form of therapies, biologics, and other drugs that may be beneficial in sustaining the life of the patient, thus increasing the market demand for the fill-finish manufacturing market in the upcoming years.
Also, the rising merger acquisitions in the fill-finish manufacturing market are expected to spur the market demand for high-quality grade drugs and instruments during the forecast period. For instance, in January 2020, the Alcami Corporation, a provider of fully-integrated custom, end-to-end custom solutions for pharmaceutical and biologics industries acquired TriPharm Services, a new-state-of the-art sterile fill-finish manufacturing center solutions, located in North Carolina. Such recent developments help in the expansion of fill-finish services to be provided to a broader spectrum of people, thus driving the overall market for the fill-finish manufacturing market positively during the given forecast period.
However, the high costs of fill-finish products and increased chances of contamination with a lack of trained professionals and others would lead to less adoption and accessibility of fill-finish manufacturing by underdeveloped or developing countries, thus acting as restraints for the market growth of fill-finish manufacturing.
The fill-finish manufacturing market saw enormous growth during the period of COVID- 19 pandemic. Owing to the rising cases of COVID- 19, the demand and the immediate surge in the production of drugs and biologics exponentially increased. Moreover, the research and developmental activities to develop vaccines and their manufacturing requirement on a large scale worldwide, further pushed the growth of the fill-finish manufacturing market. In addition, the opening of widescale manufacturing units and industries, and the increasing demand for the production of drugs and potential biologics for mass immunization to prevent any further pandemics in the future, are expected to uplift the overall fill-finish manufacturing market during the forecast period from 2024-2030.
Fill Finish Manufacturing Market Segment Analysis:
Fill Finish Manufacturing Market by product (consumables [prefilled syringes, vials, cartridges, and others], instruments [by system type {integrated and standalone}, by machine type {automated, semi-automated and manual}], by end-user (contract manufacturing organizations, pharmaceutical & biopharmaceutical companies, and others), and geography (North America, Europe, Asia-Pacific, and Rest of the World)
Based on the product segment of the Fill Finish Manufacturing Market, the consumables category is projected to register a significant growth in revenue in the overall Fill Finish Manufacturing Market during the forecast period (2024-2030).
This can be ascribed to the increasing use of consumables, the subsequent need for new consumables to maintain sterile conditions, and the rising technological developments in the form of product launches are expected to drive the demand for consumables in the product segment of the fill-finish manufacturing market.
Consumables include various types of syringes, vials, and other types of equipment that can be only used once and need to be discarded, to maintain sterile conditions. The increasing use of consumables such as vials in lyophilization, and their growing use for disposable packaging in biologics are the various factors owing to which the product segment is driving the demand for the fill-finish manufacturing market.
Thereby, considering the growing demand for this segment, numerous new products are being launched in the market. For example, in October 2022, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGaurd SA Pro Safety System for 0.5mL standard glass syringes at Interphex.
Therefore, considering the advantages and the wide applicability associated with the consumables category in the product segment, this segment is expected to generate considerable revenue thereby pushing the overall growth of the global Fill Finish Manufacturing Market during the forecast period.
Asia-Pacific is expected to register the fastest growth in CAGR in the Global Fill-Finish Manufacturing Market:
Among all the regions, Asia-Pacific is expected to register the fastest growth in CAGR in the global Fill Finish Manufacturing Market. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region. For instance, in August 2022, Lonza added capacity at its biologics manufacturing facility in Guangzhou, China, by installing a new fill-finish line unit. In addition, with the costs of material and labor being comparatively cheaper in countries such as India and China, the manufacturing process of the fill-finish market becomes easy, thus driving the global market for the fill-finish manufacturing market. Along with this, the rapid expansion of the biopharmaceutical industry could be a major factor driving the demand for fill-finish manufacturing in the region.
Countries in the Asia-Pacific region such as India and China, being the largest exporters to western companies, have increased their production of APIs. For instance, in August 2020, Wockhardt Ltd, headquartered in Mumbai, India announced a deal with the U.K. government which would supply millions of doses of numerous COVID-19 vaccines, as well as those being formed by AstraZeneca and Oxford University. As part of the deal, the company had also confined fill-and-finish capacity, being the final production step of putting vaccines into syringes or vials and packaging them.
Therefore, the above-mentioned factors are expected to bolster the growth and register a significant CAGR in the Fill Finish Manufacturing Market in the Asia-Pacific region during the forecast period.
Fill Finish Manufacturing Market Key Players:
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
Recent Developmental Activities in the Fill-Finish Manufacturing Market:
In March 2022, SGD pharma launched its ready-to-use sterile 100 ml molded glass vials, which are used for fill finish parental drug products. These glass vials help in proper drug stability and eliminate the chances of scratch on vials to enhance visual inspection.
In February 2022, Moderna and Thermo Fisher scientific underwent long-term strategic collaboration to bolster the range of aseptic fill-finish manufacturing of Spikevax, Covid-19 vaccines, and different mRNA medicines in the US.
In October 2022, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced the unveiling of its DeltaCube(TM) Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex.
Key Takeaways from the Fill-Finish Manufacturing Market Report Study
Target Audience who can be benefited from this Fill-Finish Manufacturing Market Report Study
Frequently Asked Questions for the Fill-Finish Manufacturing Market:
Fill Finish Manufacturing refers to the process of filling vials, syringes, and other storage types of equipment with the vaccine, biological & pharmaceutical drug substances along with proper packaging for mass distribution.
The global Fill Finish Manufacturing Market was valued at USD 9,592.89 million in 2023, growing at a CAGR of 9.99% during the forecast period from 2024 to 2030 to reach USD 16,947.87 million by 2030.
The Fill Finish Manufacturing market is slated to witness prosperity owing to factors such as the growing demand for fill-finish manufacturing processes, requiring less human intervention and minimal chances of contamination. The rising technological developments in the fill-finish manufacturing market along with merger acquisitions taking place in the sector are further expected to result in appreciable revenue growth for the fill-finish manufacturing market during the forecast period (2024-2030).
Some of the key market players operating in the Fill Finish Manufacturing Market include Becton, Dickinson and Company, Syntegon Technology GmbH, Industria Macchine Automatiche S.p.A., Stevanato Group, West Pharmaceutical Services, Inc., OPTIMA Packaging Group GmbH, Bausch+Strobel, Groninger & Co. GmbH, Gerresheimer AG, Maquinaria Industrial Dara, Robert Bosch, SGD Pharma, Schott AG, Nipro Corporation, Bausch Advanced Technology Group, VanRX Pharmasystems Inc., Aseptic Technologies, Reagent Chemical & Research Inc., AST, Steriline S.R.L, and others.
The Asia-Pacific region is expected to have the fastest-growing CAGR in the overall Fill Finish Manufacturing Market during the forecast period from 2024 to 2030. This can be ascribed to factors such as the increasing investments by companies in clinical research, significant improvements in healthcare infrastructure, the growing construction of fill-finish facilities, and the rising product development activities in the region.